Thursday, April 21, 2022

‘Best therapeutic choice’: WHO backs Pfizer’s COVID antiviral

UN health body says Paxlovid 'strongly recommended' for patients with non-severe disease at risk of hospital admission.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)